How the Need for an Alternative Oral Dosage Form Delivered a Patient-Centric Drug Formulation
Dysphagia can affect many people throughout their lifetime. It also represents a challenge for oral drug manufacturers. Dysphagia not only impacts patients’ ability to take solid oral dosage forms, but it can also compromise adherence. When it comes to drug development, there is value in developing medicines that are tailored to patients’ needs. This paper discusses the patient-centric approach of Adare Pharmaceuticals—experts in creating formulations that solve unmet patient needs, such as dysphagia. Gain insight into how Adare overcomes complex formulation challenges to deliver innovative solutions that meet patients’ needs and improve their acceptance of therapy. Click here to download/view the white paper.
Total Page Views: 718
